Retractable Technologies, Inc. (NYSE:RVP) CEO Acquires $14,034.79 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 18,227 shares of Retractable Technologies stock in a transaction dated Monday, February 3rd. The stock was purchased at an average cost of $0.77 per share, with a total value of $14,034.79. Following the completion of the purchase, the chief executive officer now owns 15,037,535 shares of the company’s stock, valued at approximately $11,578,901.95. This represents a 0.12 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Retractable Technologies Stock Up 1.0 %

Shares of NYSE:RVP traded up $0.01 during trading hours on Tuesday, hitting $0.80. The company’s stock had a trading volume of 23,760 shares, compared to its average volume of 105,113. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. The company has a market capitalization of $23.86 million, a price-to-earnings ratio of -1.48 and a beta of 1.96. The firm’s fifty day moving average price is $0.70 and its 200 day moving average price is $0.80. Retractable Technologies, Inc. has a 52 week low of $0.56 and a 52 week high of $1.34.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on shares of Retractable Technologies in a research report on Thursday, January 30th. They set a “hold” rating for the company.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent quarter. Institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.